スウェーデン医薬品庁と薬事規制に関する守秘取り決めを締結しました ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000170062.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. The first export request adds an external RFC 3161 timestamp before download.
スウェーデン医薬品庁と薬事規制に関する守秘取り決めを締結しました ｜報道発表資料｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page is a press release from Japan's Ministry of Health, Labour and Welfare dated July 4, 2017. It announces that Japan's MHLW and the Pharmaceuticals and Medical Devices Agency (PMDA) concluded a confidentiality agreement on pharmaceutical regulations with Sweden's Medical Products Agency (MPA) on June 28, 2017. The agreement aims to promote access to safe, effective, and high-quality products and facilitate information sharing between the two countries. It is expected to enhance the exchange of information on innovative drug development and post-market safety measures. The agreement aligns with Japan's International Pharmaceutical Regulatory Harmonization Strategy established in 2015.
